Kalium muriaticum 6x homeopathic tablets

Introduction: Thyroid disorders have become a significant global health concern, affecting millions of individuals worldwide, with substantial implications for morbidity and mortality. In India, an estimated 42 million people in 2011 grapple with thyroid-related conditions, necessitating exploration into alternative approaches like homeopathy. Objectives: This review aims to assess the efficacy of homeopathic high dilutions in management of various thyroid disorders, including subclinical hypothyroidism, Hashimoto's thyroiditis, hyperthyroidism, and autoimmune thyroiditis, by analysing a selection of clinical studies. Materials and Methods: A comprehensive literature search was conducted using electronic databases such as PubMed, SCOPUS, Google Scholar, and library catalogues. The search strategy included keywords related to homeopathy and various thyroid disorders. Inclusion criteria as well as exclusion criteria was followed. Result: 10 clinical studies out of 16 were chosen to assess homeopathic high dilutions for thyroid disorders. Results revealed reductions in anti-thyroid peroxidase antibodies for subclinical hypothyroidism with Thyroidinum 3X and personalized homeopathy. Natrium muriaticum, Phosphorus, and Iodium showed potential for Hashimoto's thyroiditis, homeopathy also lowered anti-thyroglobulin antibodies in autoimmune thyroiditis cases and normalized TSH and anti-TPO antibodies in school children. Natrum Mur, Phosphorus, and Iodium were effective for hyperthyroidism. Conclusion: Homeopathic high dilutions show promising results in management of thyroid disorders, including subclinical hypothyroidism, Hashimoto's thyroiditis, an autoimmune thyroiditis, and hyperthyroidism. These findings suggest that homeopathy could serve as a valuable alternative or complementary approach to conventional treatments, potentially benefiting individuals worldwide, including economically disadvantaged populations. Further research and scientific validation are needed to expand the application of homeopathic medicines in thyroid disorder management.  

Abstract licence: CC BY-NC-SA

Cervical radiculopathy (CR) results from compression of the cervical nerve roots of the spinal column, resulting in pain, sensory and motor deficits, and diminished reflexes. To differentiate individualized homeopathic medicines (IHMs) from identical-looking placebos in the pain management of CR. This 2-month, double-blind, randomized (2:1; verum: 78, control: 39), placebo-controlled trial was carried out on 117 adults with CR. Concomitant care advice (hot fomentations, spinal extensor exercises, and ergonomic adjustments) was administered mutually. The primary outcome was the 0–10 pain Numeric Rating Scale (NRS); the secondary outcomes were the Short-Form McGill Pain Questionnaire (SF-MPQ) and the Neck Disability Index (NDI), all measured monthly, up to 2 months. Group differences were examined on the intention-to-treat sample. Group differences achieved no significance or near significance; pain NRS ( F 1,115 = 1.164, P = 0.086), SF-MPQ total score ( F 1,115 = 0.467, P = 0.046), and NDI total score ( F 1,115 = 1.331, P = 0.211). Natrium muriaticum ( n = 17) was the most frequently prescribed medicine. While statistically pooling the results of 2 randomized controlled trials of IHMs in neck pain involving 257 participants using a random effect model using mean differences (MDs) with 95% confidence intervals (CIs), compared to the control group, IHMs demonstrated significant improvement: MD −0.57, 95% CI −1.12 to −0.03, P = 0.04. No heterogeneity ( I 2 = 0%), indicated consistency between studies in the magnitude of treatment effects. The trial could not generate any conclusive evidence that the therapy was effective beyond placebos. CTRI/2023/03/050202; UTN: U1111-1288-7475.

Abstract licence: CC BY-NC-ND

Background: Depressive disorders are among the leading causes of disability worldwide, significantly impacting individuals’ quality of life. Conventional treatments, including antidepressants and psychotherapy, are effective but often associated with side effects and limitations. Homeopathy, a holistic system of medicine, offers individualized treatment approaches that may provide benefits with fewer adverse effects. Objective: This retrospective study aims to evaluate the efficacy of individualized homeopathic treatment in patients diagnosed with depressive disorders. Materials and Methods: Medical records of 70 patients aged 18–60 years, diagnosed with Major Depressive Disorder (MDD) or Dysthymia, and treated with homeopathy for at least three months between January 2020 and December 2024 were reviewed. The Hamilton Depression Rating Scale (HDRS) was used to assess depression severity before and after treatment. Statistical analysis was performed using paired t-tests. Results: The mean HDRS score significantly decreased from 24.5 ± 4.3 at baseline to 12.3 ± 3.7 after three months of homeopathic treatment (P < 0.001). Commonly prescribed remedies included Natrum muriaticum (n = 22), Ignatia amara (n = 18), Aurum metallicum (n = 16), and Sepia officinalis (n = 14). Conclusion: Individualized homoeopathic treatment was associated with significant improvement in depressive symptoms, suggesting its potential as a complementary therapy in managing depressive disorders. Further randomized controlled trials are warranted to substantiate these findings.

Abstract licence: CC BY-NC